EyePoint, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
85.0M
on 2026-06-30, from 49.9M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
No limit
S-3ASR of 2025-10-14. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since. S-3ASR ↗
$200.0M
Cantor Fitzgerald, agreement of 2020-08-05. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
49K
Warrants of every class as tagged in the XBRL facts on 2023-03-31, exercise price $12.33. 10-Q ↗
Cash
2.7 quarters
$180.5M on 2026-06-30 ÷ $66.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-10-16 | Public offering incl. 1.50M pre-funded | 12,500,000 | $12.00 | $150.0M | 424B5 ↗ |